Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Market Analysis and Insights: Global Albumin Market
Due to the COVID-19 pandemic, the global Albumin market size is estimated to be worth US$ 5206 million in 2021 and is forecast to a readjusted size of US$ 5206 million by 2028 with a CAGR of 6.6% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Albumin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global albumin control main manufactuers include CSL, Grifols, Shire (Baxalta), Octapharma, etc., totally accounting for about 42% of the market. Asia Pacific is the largest market, with a share over 65%. As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 93%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 72%.
Global Albumin Scope and Market Size
The global Albumin market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Albumin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Segment by Application
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
CSL
Grifols
Shire (Baxalta)
Octapharma
Hualan Bio
CBPO
RAAS
Kedrion
Merck
LFB Group
Albumedix
Thermo Fisher Scientific
Market Analysis and Insights: Global Albumin Market
Due to the COVID-19 pandemic, the global Albumin market size is estimated to be worth US$ 5206 million in 2021 and is forecast to a readjusted size of US$ 5206 million by 2028 with a CAGR of 6.6% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Albumin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global albumin control main manufactuers include CSL, Grifols, Shire (Baxalta), Octapharma, etc., totally accounting for about 42% of the market. Asia Pacific is the largest market, with a share over 65%. As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 93%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 72%.
Global Albumin Scope and Market Size
The global Albumin market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Albumin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Segment by Application
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
CSL
Grifols
Shire (Baxalta)
Octapharma
Hualan Bio
CBPO
RAAS
Kedrion
Merck
LFB Group
Albumedix
Thermo Fisher Scientific
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
